12 results
8-K
EX-1.1
NEXI
Neximmune Inc
17 Jun 22
Entry into a Material Definitive Agreement
4:51pm
. §§286 and 287, the exclusion law (42 U.S.C. §1320a-7), the statutes, regulations and directives of Medicare (Title XVIII of the Social Security Act … ), Medicaid (Title XIX of the Social Security Act) and all other government funded or sponsored healthcare programs including the TRICARE
-16-
program
10-K
2020 FY
NEXI
Neximmune Inc
31 Mar 21
Annual report
4:02pm
cells or replication competent vectors, adverse publicity due to the ethical and social controversies surrounding the therapeutic use
424B4
NEXI
Neximmune Inc
16 Feb 21
Prospectus supplement with pricing info
4:38pm
competent vectors, adverse publicity due to the ethical and social controversies surrounding the therapeutic use of such technologies, and reported side
S-1/A
EX-4.1
awvz4shf
8 Feb 21
IPO registration (amended)
7:29am
S-1/A
EX-1.1
ct0w0hl nbr3
8 Feb 21
IPO registration (amended)
7:29am
S-1/A
wjbs z5k97s94
8 Feb 21
IPO registration (amended)
7:29am
S-1
8dvpn4cq69uhqj 5bya
19 Jan 21
IPO registration
4:38pm
DRS/A
kglpxdj6ajk
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
h07now l4rz19
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next